SCHEMBL3319294

SCHEMBL3319294

CC(C)(CC(=O)N1CCN(Cc2ccccc2-c2ccccc2)CC1)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.49
MGLL Q99685 1/20 0.49
HTR7 P34969 7/20 0.49
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
ALOX15 P16050 1/20 0.44
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
MCL1 Q07820 2/20 0.42
DRD2 P14416 1/20 0.41
DRD4 P21917 1/20 0.41
DRD3 P35462 1/20 0.41
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3318521 0.83 FAAH (0.54) FAAHMGLLALDH1A1KDM4EMEN1
SCHEMBL6135913 0.83 LMNA (0.56) HTR7ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3319290 0.81 FAAH (0.49) FAAHMGLLHTR7ALDH1A1KDM4E
SCHEMBL3321523 0.81 ALDH1A1 (0.42) MGLLALDH1A1KDM4EMEN1KMT2A
SCHEMBL23293594 0.78 HTR7 (0.63) FAAHMGLLHTR7ALDH1A1KDM4E
SCHEMBL30420918 0.77 HTR7 (0.53) FAAHMGLLHTR7ALDH1A1KDM4E
SCHEMBL2475088 0.77 HTR7 (0.53) FAAHMGLLHTR7ALDH1A1KDM4E
SCHEMBL3320389 0.76 MEN1 (0.61) ALDH1A1MEN1KMT2ALMNA
SCHEMBL13150696 0.75 FAAH (0.63) FAAHMGLLHTR7ALDH1A1KDM4E
SCHEMBL28230641 0.75 HTR7 (0.80) FAAHMGLLHTR7DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100125075-A1 Antibacterial Agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2010-05-20 US disclosed
US-7186719-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS (GB) 2007-03-06 US disclosed
US-20050065095-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2005-03-24 US disclosed
US-6846825-B1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2005-01-25 US disclosed
EP-1202968-A2 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2002-05-08 EP disclosed
WO-2001010834-A9 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARM (GB) 2001-08-09 WO disclosed
WO-2001010834-A2 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065095-A1 Antibacterial agents NQO2, DAO, Q6ZSR9 FAAH 1160/4885MGLL 3395/4885HTR7 2378/4885
US-20100125075-A1 Antibacterial Agents NQO2, DAO, Q6ZSR9 FAAH 1166/4885MGLL 3167/4885HTR7 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.